by Dr. Jennifer Frangos, D.O., DABOM | Apr 26, 2026 | Insurance & Coverage, Guide, Hormone Replacement Therapy
Facts checked October 25, 2026. Insurance often covers the care around testosterone: your provider visits and your lab work. At Amazing Meds, we bill both to your plan, including Aetna, Cigna, TRICARE, Blue Cross Blue Shield and UnitedHealthcare. The testosterone...
by Dr. Jennifer Frangos, D.O., DABOM | Apr 24, 2026 | Insurance & Coverage, Guide, Guide, Hormone Replacement Therapy
BioTE pellet therapy has documented side effects related to hormone peaks, delivery limitations, and insertion risks. As of 2026, multiple lawsuits allege informed consent failures and dosing-related harm. For patients experiencing instability, alternatives like...
by Dr. Jennifer Frangos, D.O., DABOM | Apr 23, 2026 | Insurance & Coverage, Guide, Guide, Hormone Replacement Therapy
Weekly testosterone injections are the most precise and adjustable alternative to pellet therapy. Unlike pellets, injections allow dose changes based on lab results and symptoms at any point—making them ideal for patients experiencing peaks, crashes, or inconsistent...
by Dr. Jennifer Frangos, D.O., DABOM | Apr 22, 2026 | Insurance & Coverage, Guide, Guide, Hormone Replacement Therapy
Mylan (Viatris) estradiol patches are currently backordered nationwide. The safest and most common solution is switching to another transdermal form—like gel or spray—which maintains the same safety profile. Most providers can transition you within 24–48 hours without...
by Dr. Jennifer Frangos, D.O., DABOM | Apr 20, 2026 | Insurance & Coverage, Guide, Guide, Hormone Replacement Therapy
TRICARE covers testosterone therapy when hypogonadism is confirmed with lab results and proper documentation. Most denials happen before approval—not because TRT is excluded, but because referrals, lab timing, or prior authorization steps are incomplete. Medically...
by Dr. Jennifer Frangos, D.O., DABOM | Apr 17, 2026 | Insurance & Coverage, Guide, Guide, Hormone Replacement Therapy
Kaiser Permanente covers hormone therapy, but access depends heavily on internal referrals, formulary rules, and its closed-network system. Most delays happen before prescriptions are even approved—often at the referral or internal review stage rather than at the...
